

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of cell killing (GO:0031342) | 5.88116309 |
| 2 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.88116309 |
| 3 | detection of other organism (GO:0098543) | 5.67783050 |
| 4 | detection of bacterium (GO:0016045) | 5.62890916 |
| 5 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.61851704 |
| 6 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.56412629 |
| 7 | positive regulation by symbiont of host defense response (GO:0052509) | 5.51260096 |
| 8 | modulation by symbiont of host defense response (GO:0052031) | 5.51260096 |
| 9 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.51260096 |
| 10 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.51260096 |
| 11 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.51260096 |
| 12 | modulation by symbiont of host immune response (GO:0052553) | 5.51260096 |
| 13 | neutrophil activation involved in immune response (GO:0002283) | 5.22158746 |
| 14 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.19208249 |
| 15 | leukocyte aggregation (GO:0070486) | 5.13302808 |
| 16 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.11716625 |
| 17 | response to peptidoglycan (GO:0032494) | 4.95281641 |
| 18 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.71151809 |
| 19 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.65043320 |
| 20 | macrophage activation involved in immune response (GO:0002281) | 4.62540074 |
| 21 | detection of external biotic stimulus (GO:0098581) | 4.61895770 |
| 22 | leukocyte migration involved in inflammatory response (GO:0002523) | 4.46562154 |
| 23 | cellular extravasation (GO:0045123) | 4.40579408 |
| 24 | regulation of gamma-delta T cell activation (GO:0046643) | 4.31915929 |
| 25 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 4.25532719 |
| 26 | neutrophil activation (GO:0042119) | 4.15959469 |
| 27 | detection of biotic stimulus (GO:0009595) | 4.08704180 |
| 28 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.03635686 |
| 29 | response to host immune response (GO:0052572) | 3.95216685 |
| 30 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.95216685 |
| 31 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.93096303 |
| 32 | detection of molecule of bacterial origin (GO:0032490) | 3.91320951 |
| 33 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.90296909 |
| 34 | negative regulation of T cell mediated immunity (GO:0002710) | 3.86039984 |
| 35 | negative regulation of interleukin-12 production (GO:0032695) | 3.84074836 |
| 36 | response to interleukin-15 (GO:0070672) | 3.82060580 |
| 37 | response to muramyl dipeptide (GO:0032495) | 3.80503557 |
| 38 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.78647978 |
| 39 | respiratory burst (GO:0045730) | 3.73502534 |
| 40 | regulation of mast cell degranulation (GO:0043304) | 3.71537123 |
| 41 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.71270920 |
| 42 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.71224634 |
| 43 | response to host (GO:0075136) | 3.71224634 |
| 44 | response to host defenses (GO:0052200) | 3.71224634 |
| 45 | immunoglobulin mediated immune response (GO:0016064) | 3.71166666 |
| 46 | granulocyte activation (GO:0036230) | 3.70726348 |
| 47 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.69031242 |
| 48 | microglial cell activation (GO:0001774) | 3.65891374 |
| 49 | myeloid cell activation involved in immune response (GO:0002275) | 3.61604479 |
| 50 | neutrophil mediated immunity (GO:0002446) | 3.50667972 |
| 51 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.49717776 |
| 52 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.49480020 |
| 53 | cellular response to interleukin-15 (GO:0071350) | 3.44137230 |
| 54 | negative thymic T cell selection (GO:0045060) | 3.43362638 |
| 55 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.38560626 |
| 56 | macrophage activation (GO:0042116) | 3.38373830 |
| 57 | negative regulation of phagocytosis (GO:0050765) | 3.36619730 |
| 58 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.35931112 |
| 59 | positive regulation of mast cell activation (GO:0033005) | 3.35324337 |
| 60 | regulation of leukocyte degranulation (GO:0043300) | 3.32499063 |
| 61 | positive thymic T cell selection (GO:0045059) | 3.31800360 |
| 62 | B cell receptor signaling pathway (GO:0050853) | 3.29328987 |
| 63 | negative T cell selection (GO:0043383) | 3.28622874 |
| 64 | regulation of B cell differentiation (GO:0045577) | 3.27473462 |
| 65 | negative regulation of interleukin-6 production (GO:0032715) | 3.27436436 |
| 66 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.27023738 |
| 67 | regulation of mast cell activation (GO:0033003) | 3.26720401 |
| 68 | leukocyte degranulation (GO:0043299) | 3.25512967 |
| 69 | germinal center formation (GO:0002467) | 3.24995789 |
| 70 | response to type I interferon (GO:0034340) | 3.21723098 |
| 71 | tolerance induction (GO:0002507) | 3.21023699 |
| 72 | cellular response to type I interferon (GO:0071357) | 3.20289307 |
| 73 | type I interferon signaling pathway (GO:0060337) | 3.20289307 |
| 74 | positive regulation of B cell differentiation (GO:0045579) | 3.17912129 |
| 75 | negative regulation of innate immune response (GO:0045824) | 3.14312194 |
| 76 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.09548540 |
| 77 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.09548540 |
| 78 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.08046767 |
| 79 | regulation of tolerance induction (GO:0002643) | 3.08024588 |
| 80 | T cell selection (GO:0045058) | 2.97795225 |
| 81 | activated T cell proliferation (GO:0050798) | 2.96068549 |
| 82 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.95165274 |
| 83 | B cell mediated immunity (GO:0019724) | 2.93833205 |
| 84 | regulation of T cell tolerance induction (GO:0002664) | 2.93416751 |
| 85 | defense response to protozoan (GO:0042832) | 2.92954916 |
| 86 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.92772559 |
| 87 | positive regulation of interferon-alpha production (GO:0032727) | 2.90666465 |
| 88 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.90186751 |
| 89 | positive regulation of mast cell degranulation (GO:0043306) | 2.90186751 |
| 90 | defense response to fungus (GO:0050832) | 2.88552331 |
| 91 | thymic T cell selection (GO:0045061) | 2.87804790 |
| 92 | myeloid leukocyte mediated immunity (GO:0002444) | 2.87771863 |
| 93 | positive regulation of granulocyte differentiation (GO:0030854) | 2.84873136 |
| 94 | regulation of regulated secretory pathway (GO:1903305) | 2.84219739 |
| 95 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.83895348 |
| 96 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.83746174 |
| 97 | mast cell activation (GO:0045576) | 2.82887549 |
| 98 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.81590732 |
| 99 | negative regulation of type 2 immune response (GO:0002829) | 2.80347119 |
| 100 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.80095707 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.95720760 |
| 2 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.43847005 |
| 3 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.42636888 |
| 4 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.36412846 |
| 5 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.35668832 |
| 6 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.85879672 |
| 7 | * VDR_24763502_ChIP-Seq_THP-1_Human | 2.84934342 |
| 8 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.84672366 |
| 9 | MYC_22102868_ChIP-Seq_BL_Human | 2.74864411 |
| 10 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.62794191 |
| 11 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.59363455 |
| 12 | MAF_26560356_Chip-Seq_TH1_Human | 2.57941086 |
| 13 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.53850149 |
| 14 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.51401546 |
| 15 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.49249556 |
| 16 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.48348694 |
| 17 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.42601886 |
| 18 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.38150090 |
| 19 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.36772334 |
| 20 | * UTX_26944678_Chip-Seq_JUKART_Human | 2.31780529 |
| 21 | MYB_26560356_Chip-Seq_TH2_Human | 2.30195510 |
| 22 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.28644690 |
| 23 | SPI1_23127762_ChIP-Seq_K562_Human | 2.26971756 |
| 24 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.25128769 |
| 25 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.24457006 |
| 26 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.23694232 |
| 27 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.22690070 |
| 28 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.22140302 |
| 29 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.11383112 |
| 30 | MAF_26560356_Chip-Seq_TH2_Human | 2.10587247 |
| 31 | MYB_26560356_Chip-Seq_TH1_Human | 2.10348231 |
| 32 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.09771793 |
| 33 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.07156420 |
| 34 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.05720251 |
| 35 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.02940066 |
| 36 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.00650771 |
| 37 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.93302784 |
| 38 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.92803248 |
| 39 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.87435252 |
| 40 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.85317824 |
| 41 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.83695068 |
| 42 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.74103517 |
| 43 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.72309928 |
| 44 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.70998515 |
| 45 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.63769629 |
| 46 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.60654980 |
| 47 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.58942008 |
| 48 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.58606727 |
| 49 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.54623447 |
| 50 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.48940650 |
| 51 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.48132842 |
| 52 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.47967542 |
| 53 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.47128078 |
| 54 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.46108724 |
| 55 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.44608022 |
| 56 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.44042741 |
| 57 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.43065327 |
| 58 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.42863721 |
| 59 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.42854497 |
| 60 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.42452071 |
| 61 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.42216820 |
| 62 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.40429895 |
| 63 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.38598320 |
| 64 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.35133851 |
| 65 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.32613281 |
| 66 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.29280285 |
| 67 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.28414490 |
| 68 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.28259897 |
| 69 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.27940770 |
| 70 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.27902419 |
| 71 | GATA1_19941826_ChIP-Seq_K562_Human | 1.25973320 |
| 72 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.22570844 |
| 73 | GATA3_26560356_Chip-Seq_TH2_Human | 1.22507812 |
| 74 | P68_20966046_ChIP-Seq_HELA_Human | 1.22265664 |
| 75 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.20771710 |
| 76 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.19597004 |
| 77 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.19213192 |
| 78 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.19170587 |
| 79 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.18365358 |
| 80 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.17530729 |
| 81 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.16406769 |
| 82 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.15283291 |
| 83 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.14327929 |
| 84 | * P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.12915921 |
| 85 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.11271471 |
| 86 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.10431167 |
| 87 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.10326481 |
| 88 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.09114647 |
| 89 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.05669491 |
| 90 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.04022246 |
| 91 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.01950762 |
| 92 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.01851548 |
| 93 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.01576671 |
| 94 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.01143712 |
| 95 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.96690151 |
| 96 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.96300213 |
| 97 | GATA2_19941826_ChIP-Seq_K562_Human | 0.94744984 |
| 98 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.94394838 |
| 99 | P300_27268052_Chip-Seq_Bcells_Human | 0.94258551 |
| 100 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.93789665 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003436_decreased_susceptibility_to | 4.40008676 |
| 2 | MP0003724_increased_susceptibility_to | 4.35733608 |
| 3 | MP0001835_abnormal_antigen_presentation | 3.41855520 |
| 4 | MP0002419_abnormal_innate_immunity | 3.06504221 |
| 5 | MP0000685_abnormal_immune_system | 2.97523850 |
| 6 | MP0003303_peritoneal_inflammation | 2.92871900 |
| 7 | MP0005671_abnormal_response_to | 2.87735916 |
| 8 | MP0005025_abnormal_response_to | 2.85235926 |
| 9 | MP0001800_abnormal_humoral_immune | 2.82131489 |
| 10 | MP0005000_abnormal_immune_tolerance | 2.72839001 |
| 11 | MP0009785_altered_susceptibility_to | 2.66315446 |
| 12 | MP0001790_abnormal_immune_system | 2.63556240 |
| 13 | MP0005387_immune_system_phenotype | 2.63556240 |
| 14 | MP0003763_abnormal_thymus_physiology | 2.62862328 |
| 15 | MP0002723_abnormal_immune_serum | 2.52240472 |
| 16 | MP0002420_abnormal_adaptive_immunity | 2.50550319 |
| 17 | MP0001819_abnormal_immune_cell | 2.48139414 |
| 18 | MP0004381_abnormal_hair_follicle | 2.40062595 |
| 19 | MP0002452_abnormal_antigen_presenting | 2.37834758 |
| 20 | MP0006082_CNS_inflammation | 2.24585979 |
| 21 | MP0004947_skin_inflammation | 2.20866809 |
| 22 | MP0003191_abnormal_cellular_cholesterol | 2.20866637 |
| 23 | MP0002396_abnormal_hematopoietic_system | 2.15547507 |
| 24 | MP0001533_abnormal_skeleton_physiology | 2.10998259 |
| 25 | MP0003300_gastrointestinal_ulcer | 2.09974786 |
| 26 | MP0003172_abnormal_lysosome_physiology | 2.09873787 |
| 27 | MP0002405_respiratory_system_inflammati | 2.09089277 |
| 28 | MP0002148_abnormal_hypersensitivity_rea | 2.00024372 |
| 29 | MP0002398_abnormal_bone_marrow | 1.98345797 |
| 30 | MP0005464_abnormal_platelet_physiology | 1.96313121 |
| 31 | MP0000716_abnormal_immune_system | 1.89003013 |
| 32 | MP0008260_abnormal_autophagy | 1.81768303 |
| 33 | MP0010155_abnormal_intestine_physiology | 1.79061711 |
| 34 | MP0009333_abnormal_splenocyte_physiolog | 1.77555049 |
| 35 | MP0009278_abnormal_bone_marrow | 1.74073060 |
| 36 | MP0001851_eye_inflammation | 1.73062429 |
| 37 | MP0002132_abnormal_respiratory_system | 1.70329443 |
| 38 | MP0002796_impaired_skin_barrier | 1.69150526 |
| 39 | MP0002722_abnormal_immune_system | 1.66618735 |
| 40 | MP0001845_abnormal_inflammatory_respons | 1.65781804 |
| 41 | MP0000465_gastrointestinal_hemorrhage | 1.61289435 |
| 42 | MP0000689_abnormal_spleen_morphology | 1.60342187 |
| 43 | MP0000703_abnormal_thymus_morphology | 1.59624790 |
| 44 | MP0002429_abnormal_blood_cell | 1.51667390 |
| 45 | MP0003828_pulmonary_edema | 1.50718151 |
| 46 | MP0003866_abnormal_defecation | 1.43097110 |
| 47 | MP0000858_altered_metastatic_potential | 1.42728394 |
| 48 | MP0002166_altered_tumor_susceptibility | 1.35028330 |
| 49 | MP0005075_abnormal_melanosome_morpholog | 1.34979231 |
| 50 | MP0005451_abnormal_body_composition | 1.33103649 |
| 51 | MP0008469_abnormal_protein_level | 1.30787365 |
| 52 | MP0003878_abnormal_ear_physiology | 1.30196133 |
| 53 | MP0005377_hearing/vestibular/ear_phenot | 1.30196133 |
| 54 | MP0000015_abnormal_ear_pigmentation | 1.28430091 |
| 55 | MP0005397_hematopoietic_system_phenotyp | 1.25116072 |
| 56 | MP0001545_abnormal_hematopoietic_system | 1.25116072 |
| 57 | MP0009764_decreased_sensitivity_to | 1.23305677 |
| 58 | MP0001873_stomach_inflammation | 1.22901223 |
| 59 | MP0003183_abnormal_peptide_metabolism | 1.21504990 |
| 60 | MP0003656_abnormal_erythrocyte_physiolo | 1.18533466 |
| 61 | MP0002277_abnormal_respiratory_mucosa | 1.15002138 |
| 62 | MP0002009_preneoplasia | 1.14401965 |
| 63 | MP0005310_abnormal_salivary_gland | 1.12478054 |
| 64 | MP0002998_abnormal_bone_remodeling | 1.07802640 |
| 65 | MP0001986_abnormal_taste_sensitivity | 1.06137357 |
| 66 | MP0004883_abnormal_blood_vessel | 1.02600048 |
| 67 | MP0003453_abnormal_keratinocyte_physiol | 1.01665987 |
| 68 | MP0001853_heart_inflammation | 0.98573318 |
| 69 | MP0005058_abnormal_lysosome_morphology | 0.95978105 |
| 70 | MP0005409_darkened_coat_color | 0.95745786 |
| 71 | MP0004264_abnormal_extraembryonic_tissu | 0.91083945 |
| 72 | MP0002138_abnormal_hepatobiliary_system | 0.90357715 |
| 73 | MP0002006_tumorigenesis | 0.87376065 |
| 74 | MP0005390_skeleton_phenotype | 0.86604435 |
| 75 | MP0001216_abnormal_epidermal_layer | 0.85301289 |
| 76 | MP0004808_abnormal_hematopoietic_stem | 0.84421752 |
| 77 | MP0005174_abnormal_tail_pigmentation | 0.84219224 |
| 78 | MP0009931_abnormal_skin_appearance | 0.83512190 |
| 79 | MP0005164_abnormal_response_to | 0.81132793 |
| 80 | MP0005076_abnormal_cell_differentiation | 0.80411296 |
| 81 | MP0005501_abnormal_skin_physiology | 0.79883345 |
| 82 | MP0002933_joint_inflammation | 0.79067790 |
| 83 | MP0009763_increased_sensitivity_to | 0.78486690 |
| 84 | MP0003806_abnormal_nucleotide_metabolis | 0.76664186 |
| 85 | MP0003075_altered_response_to | 0.75826315 |
| 86 | MP0001663_abnormal_digestive_system | 0.71044582 |
| 87 | MP0000490_abnormal_crypts_of | 0.70992364 |
| 88 | MP0003045_fibrosis | 0.70069440 |
| 89 | MP0004510_myositis | 0.69902795 |
| 90 | MP0003448_altered_tumor_morphology | 0.68418230 |
| 91 | MP0005083_abnormal_biliary_tract | 0.67620370 |
| 92 | MP0005166_decreased_susceptibility_to | 0.66827073 |
| 93 | MP0002019_abnormal_tumor_incidence | 0.66506230 |
| 94 | MP0009765_abnormal_xenobiotic_induced | 0.65503284 |
| 95 | MP0004185_abnormal_adipocyte_glucose | 0.65252636 |
| 96 | MP0010234_abnormal_vibrissa_follicle | 0.60990284 |
| 97 | MP0003795_abnormal_bone_structure | 0.57857654 |
| 98 | MP0003566_abnormal_cell_adhesion | 0.55536545 |
| 99 | MP0002095_abnormal_skin_pigmentation | 0.52988809 |
| 100 | MP0004130_abnormal_muscle_cell | 0.51940798 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 6.46504431 |
| 2 | Recurrent bacterial skin infections (HP:0005406) | 5.76600497 |
| 3 | Myositis (HP:0100614) | 5.60363380 |
| 4 | Recurrent abscess formation (HP:0002722) | 5.44858064 |
| 5 | Increased IgE level (HP:0003212) | 5.33654805 |
| 6 | Orchitis (HP:0100796) | 4.96627912 |
| 7 | Optic neuritis (HP:0100653) | 4.69888193 |
| 8 | Retrobulbar optic neuritis (HP:0100654) | 4.69888193 |
| 9 | Abnormality of macrophages (HP:0004311) | 4.61582531 |
| 10 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.50848478 |
| 11 | Stomatitis (HP:0010280) | 4.49270597 |
| 12 | Recurrent fungal infections (HP:0002841) | 4.24459876 |
| 13 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.18710827 |
| 14 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 4.11567425 |
| 15 | Gastrointestinal infarctions (HP:0005244) | 4.06329569 |
| 16 | Recurrent skin infections (HP:0001581) | 4.03832947 |
| 17 | Hypochromic microcytic anemia (HP:0004840) | 3.95610436 |
| 18 | Keratoconjunctivitis sicca (HP:0001097) | 3.89494646 |
| 19 | Keratoconjunctivitis (HP:0001096) | 3.77361410 |
| 20 | Pustule (HP:0200039) | 3.77270152 |
| 21 | Obstructive lung disease (HP:0006536) | 3.77050913 |
| 22 | Chronic obstructive pulmonary disease (HP:0006510) | 3.77050913 |
| 23 | Meningitis (HP:0001287) | 3.73392147 |
| 24 | Mediastinal lymphadenopathy (HP:0100721) | 3.72878416 |
| 25 | Recurrent cutaneous fungal infections (HP:0011370) | 3.67134434 |
| 26 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.67134434 |
| 27 | Hypochromic anemia (HP:0001931) | 3.60987733 |
| 28 | Urticaria (HP:0001025) | 3.59264638 |
| 29 | Encephalitis (HP:0002383) | 3.51284845 |
| 30 | Prolonged bleeding time (HP:0003010) | 3.46407562 |
| 31 | Gingivitis (HP:0000230) | 3.25407832 |
| 32 | Panhypogammaglobulinemia (HP:0003139) | 3.20661817 |
| 33 | Vasculitis (HP:0002633) | 3.14855317 |
| 34 | Gangrene (HP:0100758) | 3.01131228 |
| 35 | Chest pain (HP:0100749) | 2.93453249 |
| 36 | Anorexia (HP:0002039) | 2.93368992 |
| 37 | Hemoptysis (HP:0002105) | 2.91926286 |
| 38 | Spontaneous hematomas (HP:0007420) | 2.90135479 |
| 39 | Gingival bleeding (HP:0000225) | 2.80539494 |
| 40 | Inflammation of the large intestine (HP:0002037) | 2.80286926 |
| 41 | Pulmonary infiltrates (HP:0002113) | 2.78582885 |
| 42 | Granulocytopenia (HP:0001913) | 2.77583187 |
| 43 | Abnormality of nail color (HP:0100643) | 2.74839782 |
| 44 | Gastrointestinal inflammation (HP:0004386) | 2.74254332 |
| 45 | Epistaxis (HP:0000421) | 2.71992769 |
| 46 | Recurrent viral infections (HP:0004429) | 2.71906756 |
| 47 | Episodic fever (HP:0001954) | 2.65987295 |
| 48 | Arterial thrombosis (HP:0004420) | 2.65858332 |
| 49 | Cellulitis (HP:0100658) | 2.60709783 |
| 50 | Leukocytosis (HP:0001974) | 2.56061814 |
| 51 | Thick nail (HP:0001805) | 2.52962530 |
| 52 | Hypergammaglobulinemia (HP:0010702) | 2.47367748 |
| 53 | Abnormality of T cells (HP:0002843) | 2.45891105 |
| 54 | Skin ulcer (HP:0200042) | 2.44125068 |
| 55 | Abnormality of T cell physiology (HP:0011840) | 2.41888320 |
| 56 | Pulmonary embolism (HP:0002204) | 2.40102518 |
| 57 | T lymphocytopenia (HP:0005403) | 2.39948123 |
| 58 | Abnormality of T cell number (HP:0011839) | 2.37760807 |
| 59 | Sepsis (HP:0100806) | 2.35745476 |
| 60 | Osteomyelitis (HP:0002754) | 2.28228444 |
| 61 | Colitis (HP:0002583) | 2.27547594 |
| 62 | Amyloidosis (HP:0011034) | 2.26623738 |
| 63 | Microcytic anemia (HP:0001935) | 2.25415048 |
| 64 | Abnormality of the pleura (HP:0002103) | 2.24804633 |
| 65 | Cheilitis (HP:0100825) | 2.22313014 |
| 66 | Petechiae (HP:0000967) | 2.20587199 |
| 67 | Peritonitis (HP:0002586) | 2.16514179 |
| 68 | Increased IgM level (HP:0003496) | 2.16334935 |
| 69 | Keratitis (HP:0000491) | 2.15039137 |
| 70 | Palmoplantar hyperkeratosis (HP:0000972) | 2.12456727 |
| 71 | Papilloma (HP:0012740) | 2.09151963 |
| 72 | Verrucae (HP:0200043) | 2.09151963 |
| 73 | Increased serum ferritin (HP:0003281) | 2.07424613 |
| 74 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.06307996 |
| 75 | Eosinophilia (HP:0001880) | 2.06252342 |
| 76 | Lymphopenia (HP:0001888) | 2.02586110 |
| 77 | Premature loss of primary teeth (HP:0006323) | 2.01555570 |
| 78 | Abnormality of iron homeostasis (HP:0011031) | 1.95677694 |
| 79 | Agammaglobulinemia (HP:0004432) | 1.95222094 |
| 80 | Viral hepatitis (HP:0006562) | 1.93844464 |
| 81 | Abnormality of the endocardium (HP:0004306) | 1.91913212 |
| 82 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.91114869 |
| 83 | Palmar hyperkeratosis (HP:0010765) | 1.90728773 |
| 84 | Abnormality of the peritoneum (HP:0002585) | 1.90321607 |
| 85 | Slow saccadic eye movements (HP:0000514) | 1.88065266 |
| 86 | Parakeratosis (HP:0001036) | 1.87118252 |
| 87 | Skin rash (HP:0000988) | 1.86830687 |
| 88 | Purpura (HP:0000979) | 1.86705219 |
| 89 | Glomerulopathy (HP:0100820) | 1.84927490 |
| 90 | Abnormality of the fingertips (HP:0001211) | 1.84506536 |
| 91 | Increased cerebral lipofuscin (HP:0011813) | 1.84054027 |
| 92 | Plantar hyperkeratosis (HP:0007556) | 1.83667553 |
| 93 | Hepatosplenomegaly (HP:0001433) | 1.82227178 |
| 94 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.81977032 |
| 95 | Abnormality of the pericardium (HP:0001697) | 1.81470454 |
| 96 | Chronic otitis media (HP:0000389) | 1.79764020 |
| 97 | Vertigo (HP:0002321) | 1.79655574 |
| 98 | Loss of speech (HP:0002371) | 1.79628070 |
| 99 | Abnormal blistering of the skin (HP:0008066) | 1.78055389 |
| 100 | Abnormality of eosinophils (HP:0001879) | 1.77878875 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RIPK4 | 4.28868635 |
| 2 | MAP4K1 | 3.66130190 |
| 3 | MAP2K3 | 3.29488676 |
| 4 | BLK | 2.98308002 |
| 5 | ERN1 | 2.95098285 |
| 6 | IRAK4 | 2.83544745 |
| 7 | TNK2 | 2.53646265 |
| 8 | TYK2 | 2.48328022 |
| 9 | FES | 2.35218442 |
| 10 | CSK | 2.28155607 |
| 11 | ZAP70 | 2.18441462 |
| 12 | TXK | 2.07511831 |
| 13 | * GRK6 | 2.05122756 |
| 14 | BTK | 2.01194689 |
| 15 | PRPF4B | 1.97107191 |
| 16 | MAP3K3 | 1.95150523 |
| 17 | JAK3 | 1.80025909 |
| 18 | TAOK3 | 1.74053632 |
| 19 | EPHB1 | 1.73972662 |
| 20 | MAP3K14 | 1.70851513 |
| 21 | HCK | 1.63878432 |
| 22 | SYK | 1.63277810 |
| 23 | MAP3K13 | 1.62410758 |
| 24 | TRIB3 | 1.60590470 |
| 25 | MAP3K6 | 1.52341696 |
| 26 | TAOK1 | 1.51432723 |
| 27 | MAP3K11 | 1.51133547 |
| 28 | IKBKE | 1.44071055 |
| 29 | TBK1 | 1.42684298 |
| 30 | SIK3 | 1.40848046 |
| 31 | KIT | 1.37936753 |
| 32 | MAP3K1 | 1.37305718 |
| 33 | FGR | 1.32558989 |
| 34 | SIK2 | 1.29736685 |
| 35 | PRKD2 | 1.28569341 |
| 36 | ITK | 1.26003142 |
| 37 | LYN | 1.25507863 |
| 38 | MARK3 | 1.20282603 |
| 39 | MAP3K2 | 1.19105948 |
| 40 | KSR2 | 1.17888870 |
| 41 | JAK1 | 1.17301063 |
| 42 | IKBKB | 1.16678614 |
| 43 | LCK | 1.16119138 |
| 44 | TEC | 1.10217410 |
| 45 | SMG1 | 1.08389998 |
| 46 | SIK1 | 1.08175196 |
| 47 | JAK2 | 1.06903549 |
| 48 | MAP2K6 | 1.06021414 |
| 49 | CSF1R | 1.05969266 |
| 50 | MARK2 | 1.04316745 |
| 51 | MAP3K7 | 1.01746105 |
| 52 | MAPK7 | 0.95006780 |
| 53 | PTK6 | 0.92257821 |
| 54 | IRAK1 | 0.91527834 |
| 55 | YES1 | 0.84690130 |
| 56 | FGFR3 | 0.83336093 |
| 57 | CDK12 | 0.82105789 |
| 58 | MATK | 0.81904578 |
| 59 | FGFR4 | 0.79538392 |
| 60 | HIPK2 | 0.79014354 |
| 61 | PDK1 | 0.76650790 |
| 62 | MAPK12 | 0.74182114 |
| 63 | MAP2K4 | 0.72943404 |
| 64 | STK10 | 0.71964499 |
| 65 | PDPK1 | 0.68987860 |
| 66 | RPS6KL1 | 0.64682424 |
| 67 | RPS6KC1 | 0.64682424 |
| 68 | IRAK2 | 0.63208617 |
| 69 | PTK2B | 0.61173957 |
| 70 | TESK2 | 0.61048650 |
| 71 | CDC42BPA | 0.60403894 |
| 72 | RPS6KA6 | 0.59757122 |
| 73 | PIK3CG | 0.56377489 |
| 74 | CDK4 | 0.54789581 |
| 75 | RAF1 | 0.54643466 |
| 76 | FYN | 0.52113961 |
| 77 | MAP2K2 | 0.51610580 |
| 78 | MAPKAPK2 | 0.51571051 |
| 79 | RET | 0.50791155 |
| 80 | CDK19 | 0.46895297 |
| 81 | TAOK2 | 0.44861847 |
| 82 | PRKCQ | 0.44441421 |
| 83 | LRRK2 | 0.42711554 |
| 84 | BMPR2 | 0.42658073 |
| 85 | STK11 | 0.42075346 |
| 86 | EPHA3 | 0.40624744 |
| 87 | MUSK | 0.40236315 |
| 88 | SGK3 | 0.39463818 |
| 89 | RPS6KA2 | 0.39296424 |
| 90 | BRD4 | 0.37786849 |
| 91 | TGFBR2 | 0.33469107 |
| 92 | PIM1 | 0.33389483 |
| 93 | PKN2 | 0.32525753 |
| 94 | DYRK1B | 0.31272041 |
| 95 | MAPK11 | 0.29711250 |
| 96 | ABL1 | 0.28590474 |
| 97 | RPS6KA1 | 0.27254546 |
| 98 | CHUK | 0.24425855 |
| 99 | STK38 | 0.24291629 |
| 100 | PRKCH | 0.24185602 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Leishmaniasis_Homo sapiens_hsa05140 | 2.92232184 |
| 2 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.88946479 |
| 3 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.67175754 |
| 4 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.36720348 |
| 5 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.32085854 |
| 6 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.31989521 |
| 7 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.29868789 |
| 8 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 2.13397876 |
| 9 | Allograft rejection_Homo sapiens_hsa05330 | 2.07224155 |
| 10 | Tuberculosis_Homo sapiens_hsa05152 | 2.03999000 |
| 11 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 2.00547086 |
| 12 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.00293221 |
| 13 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.98904869 |
| 14 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.91242022 |
| 15 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.89790361 |
| 16 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.83823652 |
| 17 | Malaria_Homo sapiens_hsa05144 | 1.80781791 |
| 18 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.77561658 |
| 19 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.72449971 |
| 20 | Measles_Homo sapiens_hsa05162 | 1.71488454 |
| 21 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.69434466 |
| 22 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.63739980 |
| 23 | Other glycan degradation_Homo sapiens_hsa00511 | 1.62303452 |
| 24 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.57958300 |
| 25 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.54142514 |
| 26 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.54027107 |
| 27 | Influenza A_Homo sapiens_hsa05164 | 1.53221717 |
| 28 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.49425912 |
| 29 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.47722887 |
| 30 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.46142607 |
| 31 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.39731752 |
| 32 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.37623741 |
| 33 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.27829592 |
| 34 | Platelet activation_Homo sapiens_hsa04611 | 1.26310600 |
| 35 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.24854881 |
| 36 | Asthma_Homo sapiens_hsa05310 | 1.22953977 |
| 37 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.21948893 |
| 38 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.20322453 |
| 39 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.19373608 |
| 40 | Hepatitis B_Homo sapiens_hsa05161 | 1.16484934 |
| 41 | Viral myocarditis_Homo sapiens_hsa05416 | 1.13404984 |
| 42 | Hepatitis C_Homo sapiens_hsa05160 | 1.11223637 |
| 43 | Legionellosis_Homo sapiens_hsa05134 | 1.10564212 |
| 44 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.09629896 |
| 45 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.09506834 |
| 46 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.07664436 |
| 47 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.05853349 |
| 48 | Pertussis_Homo sapiens_hsa05133 | 0.98802043 |
| 49 | Phagosome_Homo sapiens_hsa04145 | 0.96461253 |
| 50 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.93686866 |
| 51 | Shigellosis_Homo sapiens_hsa05131 | 0.92754058 |
| 52 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.91783366 |
| 53 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.86100951 |
| 54 | Apoptosis_Homo sapiens_hsa04210 | 0.84925469 |
| 55 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.84807466 |
| 56 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.83285442 |
| 57 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.82218449 |
| 58 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.81353664 |
| 59 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.81352728 |
| 60 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.77134808 |
| 61 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.75068418 |
| 62 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.75048385 |
| 63 | Salmonella infection_Homo sapiens_hsa05132 | 0.73818650 |
| 64 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.73539675 |
| 65 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.71779355 |
| 66 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.71122248 |
| 67 | Lysosome_Homo sapiens_hsa04142 | 0.68995461 |
| 68 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.68978341 |
| 69 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.67957371 |
| 70 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.65877667 |
| 71 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.65094757 |
| 72 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.64679380 |
| 73 | Endocytosis_Homo sapiens_hsa04144 | 0.64523014 |
| 74 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.64003622 |
| 75 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.63866009 |
| 76 | Insulin resistance_Homo sapiens_hsa04931 | 0.62457193 |
| 77 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.61714457 |
| 78 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.60766831 |
| 79 | HTLV-I infection_Homo sapiens_hsa05166 | 0.60377620 |
| 80 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.59821826 |
| 81 | Amoebiasis_Homo sapiens_hsa05146 | 0.58914266 |
| 82 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.58621531 |
| 83 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.58498422 |
| 84 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.57286089 |
| 85 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.57230742 |
| 86 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.56513924 |
| 87 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.56452182 |
| 88 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.55442916 |
| 89 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.54049184 |
| 90 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.53199605 |
| 91 | Endometrial cancer_Homo sapiens_hsa05213 | 0.51342483 |
| 92 | Colorectal cancer_Homo sapiens_hsa05210 | 0.49107337 |
| 93 | Prostate cancer_Homo sapiens_hsa05215 | 0.46082037 |
| 94 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.45058457 |
| 95 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.44996069 |
| 96 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.44965255 |
| 97 | Glioma_Homo sapiens_hsa05214 | 0.43265429 |
| 98 | Bladder cancer_Homo sapiens_hsa05219 | 0.41179872 |
| 99 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.39852200 |
| 100 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.39208129 |

